4.3 Article

The Role of Hyperbaric Oxygen in the Treatment of Diabetic Foot Ulcers

期刊

ANGIOLOGY
卷 63, 期 4, 页码 302-314

出版社

SAGE PUBLICATIONS INC
DOI: 10.1177/0003319711416804

关键词

diabetic foot; chronic ulcers; hyperbaric oxygen treatment

资金

  1. Novo Nordisk
  2. Novartis
  3. Miro
  4. Sanofi-Aventis
  5. Wyeth
  6. Pfizer
  7. Bayer

向作者/读者索取更多资源

Diabetic foot ulcers are still extremely difficult to heal. Therefore, therapeutic options to improve healing rates are continuously being explored. Hyperbaric oxygen (HBO) has been used in addition to standard treatment of the diabetic foot for more than 20 years. Evidence suggests that HBO reduces amputation rates and increases the likelihood of healing in infected diabetic foot ulcers, in association with improved tissue oxygenation, resulting in better quality of life. Nonetheless, HBO represents an expensive modality, which is only available in few centers. Moreover, adverse events necessitate a closer investigation of its safety. Finally, it is not entirely clear which patients stand to benefit from HBO and how these should be selected. In conclusion, HBO appears promising, but more experience is needed before its broad implementation in the routine care of the diabetic foot.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据